The theoretical advantage of neo-adjuvant therapy contains reducing micro-metastases and shrinkage of the primary tumour and equally these factors are connected to a reduced incidence of tumour recurrence[108]. On the other hand, patients getting neo-adjuvant cure may develop problems which often can delay or reduce the progression to operation https://directivepublications.org/world-journal-of-clinical-cancer-research/